The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)

被引:36
|
作者
Feliciano, David M. [1 ]
机构
[1] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA
来源
FRONTIERS IN NEUROANATOMY | 2020年 / 14卷
基金
美国国家卫生研究院;
关键词
TSC1; TSC2; mTOR; Tuber; SEGA; subependymal giant cell astrocytoma; FOCAL CORTICAL DYSPLASIA; GIANT-CELL ASTROCYTOMAS; AUTISTIC-LIKE BEHAVIOR; INDUCED RENAL TUMORS; EKER RAT MODEL; MOUSE MODEL; SOMATIC MUTATIONS; EPILEPSY SURGERY; MAMMALIAN TARGET; MTOR PATHWAY;
D O I
10.3389/fnana.2020.00039
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Tuberous sclerosis complex (TSC) is a model disorder for understanding brain development because the genes that cause TSC are known, many downstream molecular pathways have been identified, and the resulting perturbations of cellular events are established. TSC, therefore, provides an intellectual framework to understand the molecular and biochemical pathways that orchestrate normal brain development. The TSC1 and TSC2 genes encode Hamartin and Tuberin which form a GTPase activating protein (GAP) complex. Inactivating mutations in TSC genes (TSC1/TSC2) cause sustained Ras homologue enriched in brain (RHEB) activation of the mammalian isoform of the target of rapamycin complex 1 (mTORC1). TOR is a protein kinase that regulates cell size in many organisms throughout nature. mTORC1 inhibits catabolic processes including autophagy and activates anabolic processes including mRNA translation. mTORC1 regulation is achieved through two main upstream mechanisms. The first mechanism is regulation by growth factor signaling. The second mechanism is regulation by amino acids. Gene mutations that cause too much or too little mTORC1 activity lead to a spectrum of neuroanatomical changes ranging from altered brain size (micro and macrocephaly) to cortical malformations to Type I neoplasias. Because somatic mutations often underlie these changes, the timing, and location of mutation results in focal brain malformations. These mutations, therefore, provide gain-of-function and loss-of-function changes that are a powerful tool to assess the events that have gone awry during development and to determine their functional physiological consequences. Knowledge about the TSC-mTORC1 pathway has allowed scientists to predict which upstream and downstream mutations should cause commensurate neuroanatomical changes. Indeed, many of these predictions have now been clinically validated. A description of clinical imaging and histochemical findings is provided in relation to laboratory models of TSC that will allow the reader to appreciate how human pathology can provide an understanding of the fundamental mechanisms of development.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Tuberous sclerosis complex (TSC) in the Republic of Ireland - making the invisible visible
    Vasseghi, M.
    Behan, C.
    Connolly, A.
    Cunningham, D.
    Dempsey, E.
    Flynn, C.
    Galvin, M.
    Goulding, D.
    Griffin, G.
    Moloney, P.
    Murphy, M.
    Owen, Y.
    O'Malley, S.
    O'Rourke, G.
    O'Sullivan, O.
    Doherty, C. P.
    EPILEPSIA, 2023, 64 : 329 - 330
  • [42] EVEROLIMUS REDUCES SEIZURE ACTIVITY IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC)
    Franz, D. N.
    Tillema, J. M.
    Care, M. M.
    Holland-Bouley, K.
    Agricola, K.
    Tudor, C.
    Mangeshkar, P.
    Weber-Byars, A.
    Sahmoud, T.
    Krueger, D. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 568 - 568
  • [43] Tuberous Sclerosis Complex (TSC): Expert Recommendations for Provision of Coordinated Care
    Annear, Nicholas M. P.
    Appleton, Richard E.
    Bassi, Zahabiyah
    Bhatt, Rupesh
    Bolton, Patrick F.
    Crawford, Pamela
    Crowe, Alex
    Tossi, Maureen
    Elmslie, Frances
    Finlay, Eric
    Gale, Daniel P.
    Henderson, Alex
    Jones, Elizabeth A.
    Johnson, Simon R.
    Joss, Shelagh
    Kerecuk, Larissa
    Lipkin, Graham
    Morrison, Patrick J.
    O'Callaghan, Finbar J.
    Cadwgan, Jill
    Ong, Albert C. M.
    Sampson, Julian R.
    Shepherd, Charles
    Kingswood, J. Chris
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [44] A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC)
    Zoellner, Johann Philipp
    Franz, David Neal
    Hertzberg, Christoph
    Nabbout, Rima
    Rosenow, Felix
    Sauter, Matthias
    Schubert-Bast, Susanne
    Wiemer-Kruel, Adelheid
    Strzelczyk, Adam
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [45] Tuberous sclerosis complex (TSC): A comparison of high resolution EEG and MEG
    Huiskamp, GJ
    Jansen, FE
    Van Nieuwenhuizen, O
    Bourez-Swart, MD
    Boere, E
    Gebbink, TA
    Vincken, KL
    Van Huffelen, AC
    EPILEPSIA, 2005, 46 : 64 - 64
  • [46] Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations
    Curatolo, Paolo
    Jozwiak, Sergiusz
    Nabbout, Rima
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2012, 16 (06) : 582 - 586
  • [47] An adolescent girl with tuberous sclerosis complex and acne - TSC with comorbid acne
    Keri, Jonette E.
    Avashia, Nidhi
    PEDIATRIC ANNALS, 2006, 35 (06): : 433 - 435
  • [48] Rhebbing up mTOR - New insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis
    Kwiatkowski, DJ
    CANCER BIOLOGY & THERAPY, 2003, 2 (05) : 471 - 476
  • [49] Tuber or Not Tuber: The Question of Epileptogenic Lesions in Tuberous Sclerosis Complex (TSC)
    Chang, Bernard S.
    EPILEPSY CURRENTS, 2013, 13 (05) : 207 - 208
  • [50] THE NATURAL HISTORY OF RENAL ANGIOMYOLIPOMATA (AMLS) IN TUBEROUS SCLEROSIS COMPLEX (TSC)
    Cox, Jane
    Kingswood, John
    Mbundi, Jana
    Attard, Ginny
    Patel, Uday
    Saggar, Anand
    Elmslie, Frances
    Doyle, Tim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 325 - 325